Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Elnaz Roohi

1 paper in the library · publishing 2024

Papers

Therapeutic Effects of Tamsulosin in Nightmare Disorder: A Randomized, Double Blind, Placebo-Controlled, Cross-Over, Pilot Study.

Drug research February 1, 2024 Negin Naderifar, Elnaz Roohi, Ali Sharifi et al.

A small pilot study tested whether tamsulosin, a drug that blocks specific adrenoceptors, could reduce nightmares. In a randomized, double-blind, crossover trial, patients took either tamsulosin 0.4 mg daily or a placebo for four weeks, then switched after a two-week washout. Nightmare severity, measured by the Disturbing Dreams and Nightmares Severity Index, decreased after tamsulosin, with a statistical trend toward significance in one analysis and a significant difference in another. Placebo also reduced scores, but not significantly in one analysis. Tamsulosin may help treat nightmare disorder, but larger trials are needed.